Even as Bayer continues cutting costs across its conglomerate, it’s still making some small R&D deals to add to its pipeline.
On Wednesday, the German …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: – Benchstrength, a New York City-based venture capital firm, has announced the close of its first $62M fund, focused on investing
MADRID — Including pembrolizumab (Keytruda) in the first-line treatment of metastatic HER2-positive gastric or gastroesophageal cancer improved progression-free survival (PFS), but potential harm was seen
Eckert & Ziegler SE / Key word(s): Quarter Results/Preliminary Results Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year.